Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2019
DOI: 10.1016/j.psychres.2018.11.042
|View full text |Cite
|
Sign up to set email alerts
|

Examining the factor structure of the self-report Yale-Brown Obsessive Compulsive Scale Symptom Checklist

Abstract: Obsessive-compulsive symptom dimensions are important in studies about the pathogenesis and treatment of obsessive-compulsive disorder. More than 30 factor analytic studies using the Yale-Brown Obsessive Compulsive Scale Symptom Checklist (Y-BOCS-SC) interview version have been published. However, a drawback of the Y-BOCS-SC interview is that it is time-consuming for the clinician. Baer's self-report version of the Y-BOCS-SC could be a less time-consuming alternative. The purpose of this study was to examine t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 47 publications
0
6
0
Order By: Relevance
“…The YBOCS-SR contains both a symptom checklist and a severity measure, totalling 69 items, however, in line with Leckman et al (1997), the miscellaneous section of the checklist was excluded from analysis, leaving 52 items. Following previous research (e.g., du Mortier et al, 2019;Wu et al, 2007) response scales were adjusted from dichotomous to dimensional 5-point Likert scales (0 = Not present, through to 4 = Very Severe). Items were assigned to symptom clusters per Leckman et al (1997).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The YBOCS-SR contains both a symptom checklist and a severity measure, totalling 69 items, however, in line with Leckman et al (1997), the miscellaneous section of the checklist was excluded from analysis, leaving 52 items. Following previous research (e.g., du Mortier et al, 2019;Wu et al, 2007) response scales were adjusted from dichotomous to dimensional 5-point Likert scales (0 = Not present, through to 4 = Very Severe). Items were assigned to symptom clusters per Leckman et al (1997).…”
Section: Methodsmentioning
confidence: 99%
“…One explanation might be the well-documented heterogeneity within the diagnostic category of OCD (e.g., Abramowitz & Jacoby, 2014). For example, four robust symptom dimensions have been identified in multiple symptom measures of OCD: (1) obsession and checking, (2) symmetry and ordering, (3) washing and contamination, and (4) hoarding (e.g., Bloch et al, 2008;du Mortier et al, 2019;Leckman et al, 1997;Stein et al, 2010;Summerfeldt et al, 2010;Summerfeldt, Richter, Antony, & Swinson, 1999;Watson et al, 2004). We turn now to briefly discuss each of these symptom dimensions, and available evidence regarding their patterns of co-occurrence with other domains of psychopathology.…”
Section: Ocd In An Empirical Model Of Psychopathologymentioning
confidence: 99%
“…Individual-level CIDI-SCID diagnostic concordance was next evaluated by calculating area under the receiver operator characteristic curve (AUC; Hanley & McNeil, 1982). Although Cohen's Îș (Cohen, 1960) is a much more widely used measure of concordance in validity studies of psychiatric disorders, Îș is dependent on prevalence and consequently is often low in situations where there appears to be high agreement between low-prevalence measures (Byrt, Bishop, & Carlin, 1993;Cook, 1998;Kraemer et al, 2003). An important implication is that Îș varies across populations that differ in prevalence even when the populations do not differ in sensitivity (SN; the percent of true cases correctly classified by the CIDI) or specificity (SP; the percent of true noncases correctly classified).…”
Section: Analysis Methodsmentioning
confidence: 99%
“…It has demonstrated both good interrater reliability for the total score ( r s between 0.80 and 0.97) and 2-week test–retest reliability (between 0.81 and 0.97) and has shown excellent treatment sensitivity (Goodman et al, 1989; Steketee et al, 1996). Previous research has supported the use of self-report Y-BOCS as a moderately effective alternative to the clinician-administered versions in clinical samples (du Mortier et al, 2019; Hauschildt et al, 2019). In the current study, the internal consistency (Cronbach’s α ) at pretreatment was 0.71.…”
Section: Methodsmentioning
confidence: 99%